Atlas Trials

Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer

Clinical trial NCT01283217 · UNKNOWN

Trial details

NCT number
NCT01283217
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Adenocarcinoma
Start date
2010-03-01
Primary completion
2016-03-01
Enrollment
166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.